Influencing factors of poor prognosis in patients with severe craniocerebral trauma treated by hyperbaric oxygen therapy
Objective:To analyze influencing factors of poor prognosis in patients with severe craniocerebral trauma treated by hyperbaric oxygen therapy. Methods:A cross-sectional study was conducted on 100 patients with severe craniocerebral trauma admitted to this hospital from 2020 to 2022. After 6 months of hyperbaric oxygen therapy,the prognostic effect was evaluated using the disability rating scale (DRS). According to whether the prognosis was poor,they were divided into poor prognosis group[DRS score ≥ 12 points]and good prognosis group[DRS score<12 points . Logistic regression was used to analyze the influencing factors of poor prognosis in the patients with severe craniocerebral trauma treated with hyperbaric oxygen. Results:After 6 months of hyperbaric oxygen therapy for the 100 patients with severe craniocerebral trauma,36 patients with DRS score ≥ 12 points (accounting for 36.00％) were set as the poor prognosis group,and the rest were set as the good prognosis group. The proportions of the patients with Glasgow Coma Scale (GCS) score<5 points at admission,combined neurological complications,and hyperbaric oxygen therapy time of more than 30 days after admission in the poor prognosis group were higher than those in the good prognosis group,and the differences were statistically significant (P<0.05). Logistic regression analysis showed that GCS score<5 points at admission,combined neurological complications,and hyperbaric oxygen therapy time of more than 30 days after admission were all risk factors for poor prognosis in the patients with severe craniocerebral trauma treated with hyperbaric oxygen therapy (OR>1,P<0.05). Conclusions:GCS score<5 points at admission,combined neurological complications,and hyperbaric oxygen therapy time of more than 30 days after admission are the risk factors for poor prognosis in the patients with severe craniocerebral trauma treated with hyperbaric oxygen.
万方数据
维普
